Ardsley Advisory Partners LP Atri Cure, Inc. Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$26.38 - $33.34 $395,700 - $500,100	-15,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$27.62 - $35.58 $138,100 - $177,900	-5,000 Reduced 25.0%	15,000 $525,000
Q1 2018 May 15, 2018	BUY	$15.05 - $21.03 $37,625 - $52,575	2,500 Added 14.29%	20,000 $410,000
Q4 2017 Feb 14, 2018	BUY	$17.69 - $23.44 $44,225 - $58,600	2,500 Added 16.67%	17,500 $319,000
Q2 2017 Sep 21, 2017	BUY	N/A	15,000	15,000 $364,000

213

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.88B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.